UCB at AES 2026

Dec 4–8, 2026 Denver, CO ~6.2k attendees Website

UCB at AES 2026 in Denver: Booth 2301, 2607.

OrganizationAES 2026 Attendance
UCB
Smyrna, GA
ucb-usa.com
Epilepsy drug and therapy developers
Belgian biopharma focused on neurology and immunology; its epilepsy medicines include Briviact, Fintepla and Nayzilam.
Booth
Exhibiting at Booth 2301, 2607
Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm

Explore the full AES 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Denver. Leave your work email and we’ll be in touch.

Privacy

Download the full AES 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from UCB

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the American Epilepsy Society. Organization details are derived from AES’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction